BioLineRx Ltd. ADR Company Profile
NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BioLineRx at a glance
BioLineRx Ltd. ADR (NASDAQ: BLRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Hevel Modi'in, Israel. BioLineRx employs about 20 people. At a market capitalization of $4.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001498403, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does BioLineRx do?
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- BioLineRx Ltd. ADR
- Ticker
- NASDAQ: BLRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 20
- Headquarters
- Modi’in Technology Park, Hevel Modi'in, Israel
- Phone
- 972 8 642 9100
- Website
- biolinerx.com
- Market cap
- $4.80M
- SEC CIK
- 0001498403
Companies similar to BioLineRx
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PULMPulmatrix Inc. | 1.27 | -10.56% | $4.64M | vs BLRX |
| SNGXSoligenix Inc. | 0.2201 | -8.29% | $5.14M | vs BLRX |
| PCSAProcessa Pharmaceuticals Inc. | 1.56 | -7.69% | $4.37M | vs BLRX |
| CANFCan-Fite Biopharma Ltd ADR | 1.44 | -2.34% | $4.35M | vs BLRX |
| CNSPCNS Pharmaceuticals Inc. | 3.56 | -12.75% | $5.25M | vs BLRX |
| UPCUniverse Pharmaceuticals Inc. Class A | 1.08 | -20.59% | $5.43M | vs BLRX |
| TOVXTheriva Biologics Inc. | 0.12 | -6.25% | $5.51M | vs BLRX |
| SCNXScienture Holdings Inc. | 2.28 | -6.45% | $4.07M | vs BLRX |